_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc-preview-1.jpg "80mg regorafenib plus pembrolizumab for 1L HCC from regorafenib nivolumab asco Video Screenshot Preview 1")
Gallery_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc-preview-3.jpg "80mg regorafenib plus pembrolizumab for 1L HCC from regorafenib nivolumab asco Video Screenshot Preview 3")
Gallery_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc-preview-hqdefault.jpg "80mg regorafenib plus pembrolizumab for 1L HCC from regorafenib nivolumab asco Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 4 minutes 7 seconds
👁 View: 32 times
Play Audio:👁 View: 32 times
Description:
VJOncology
VJOncology
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc.webp "VJOncology")
_therapeutic-approach-for-hcc-progression.webp "Targeted Oncology")
_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc.webp "VJOncology")
⏲ 2 minutes 52 seconds 👁 46
_the-rationale-for-combining-regorafenib-with-io-to-treat-patients-with-refractory-mss-crc.webp "VJOncology")
⏲ 1 minute 23 seconds 👁 48
_dr-lopes-on-the-fda-approval-of-nivolumab-ipilimumab-in-nsclc.webp "OncLiveTV")
_real-world-use-of-nivolumab-in-gastric-cancer.webp "VJOncology")
_alan-venook-md-relays-the-optimal-dose-for-regorafenib-stivarga-in-the-2nd-line-treatment-of-mcrc.webp "OBRoncology")
Alan Venook, MD relays the optimal dose for regorafenib (Stivarga) in the 2nd line treatment of mCRC
⏲ 1 minute 47 seconds 👁 61
_checkmate577-nivolumab-in-ec-gejc.webp "VJOncology")
_80mg-regorafenib-plus-pembrolizumab-for-1l-hcc.jpg)
_therapeutic-approach-for-hcc-progression.jpg)
_refine-a-real-world-analysis-of-regorafenib-in-patients-with-unresectable-hcc.jpg)
_the-rationale-for-combining-regorafenib-with-io-to-treat-patients-with-refractory-mss-crc.jpg)
_dr-lopes-on-the-fda-approval-of-nivolumab-ipilimumab-in-nsclc.jpg)
_real-world-use-of-nivolumab-in-gastric-cancer.jpg)
_alan-venook-md-relays-the-optimal-dose-for-regorafenib-stivarga-in-the-2nd-line-treatment-of-mcrc.jpg)
_checkmate577-nivolumab-in-ec-gejc.jpg)
![[+]](/images/menu.gif){kind=small}